Open Access

Nintedanib: beneficial agent in post-COVID-19 Pulmonary Fibrosis

, , , , ,  and   
Jun 19, 2024

Cite
Download Cover

Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Clinical Medicine, Clinical Medicine, other, Internal Medicine, Pneumology